AlphaFold predicted structure
PPP1R13L · Q8WUF5

Mean pLDDT
57.2/ 100
Low
828 residues
Confidence breakdown
- Very high(≥ 90)24%
- Confident(70–90)9%
- Low(50–70)9%
- Very low(< 50)58%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
protein phosphatase 1 regulatory subunit 13 like
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalDilated Cardiomyopathy and conduction defects
BIALLELIC, autosomal or pseudoautosomalEctodermal dysplasia
BIALLELIC, autosomal or pseudoautosomalPaediatric or syndromic cardiomyopathy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalSudden death in young people
BIALLELIC, autosomal or pseudoautosomalarrhythmogenic cardiomyopathy with variable ectodermal abnormalities
dilated cardiomyopathy
Microcephaly - facio-cardio-skeletal syndrome, Hadziselimovic type
sudden cardiac arrest
multiple congenital anomalies/dysmorphic syndrome
orofacial cleft
hereditary disease
Abnormality of the cardiovascular system
subarachnoid hemorrhage
familial hyperlipidemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
RelA-associated inhibitor
Regulator that plays a central role in regulation of apoptosis and transcription via its interaction with NF-kappa-B and p53/TP53 proteins. Blocks transcription of HIV-1 virus by inhibiting the action of both NF-kappa-B and SP1. Also inhibits p53/TP53 function, possibly by preventing the association between p53/TP53 and ASPP1 or ASPP2, and therefore suppressing the subsequent activation of apoptosis (PubMed:12524540). Is involved in NF-kappa-B dependent negative regulation of inflammatory response (PubMed:28069640)
PPP1R13L · Q8WUF5

Mean pLDDT
57.2/ 100
Low
828 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0